Skip to Main Content

Paper Details

TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
Pharmacol Res
3
2021
-, BRAF, BRAFi, BRAFi- and BRAFi/MEKi-resistant cells, BRAFi/MEKi-resistant cells, DNA Single-Strand Break Repair genes, MEK, MEKi, MITF, TOP1, cancer, melanoma, melanomas, metastatic, metastatic cells, metastatic melanoma, non-malignant cells, resistant cell types, resistant cells, sensitive, therapy
Author NameAffiliation
Gordon B MillsOregon Health & Science University
Gordon B MillsOregon Health & Science University
Yiling LuThe University of Texas MD Anderson Cancer Center
Colin R GodingLudwig Institute for Cancer Research, University of Oxford
  • 1 - 4

Datasets

Release 1.2